Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
Submitted by
admin
on March 31, 2023 - 10:37am
Source:
CNBC
News Tags:
Illumina
Carl Icahn
Grail
M&A
Headline:
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
snippet:
Illumina urged shareholders to reject Carl Icahn’s three board nominees at the next annual meeting.
The DNA-sequencing company said in a preliminary proxy statement that Carl Icahn’s board nominees would “threaten the progress” of its core business.
Illumina’s remarks are its latest move in a brewing proxy fight with Icahn, who owns a 1.4% stake in the company.
Do Not Allow Advertisers to Use My Personal information
